In a reflection by N.A. Talpur and...

In a reflection by N.A. Talpur and colleagues, which appeared in The FASEB Journal (2000) three arranges of 10 patients each received a placebo, a patented form of chromium polynicotinate (ChromeMate), or ChromeMate plus a patented form of grape se extract (ActiVin). through the whole extent of 2 months, the total cholesterol flats of those taking ChromeMate alone decreased on 10 percent; the ChromeMate/ActiVin combo assemblage experienced a 16.5 percent small quantity in total cholesterol. The decreases in LDL or "bad," cholesterol were calm more dramatic: 14 percent in the ChromeMate assign places to and 20 percent in the combo assign places to The authors concluded that "[ActiVin] and ChromeMate taken in combination significantly reduc elevated cholesterol of the same heights in hypercholesterolemic patients."

COPYRIGHT 2000 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2000 Gale Group